Det anbefales ikke at sænke plasma tyrosinkoncentrationen ved reduktion eller afbrydelse af nitisinon, da den metaboliske defekt kan resultere i forværring af patientens kliniske tilstand.
It is not recommended to lower the plasma tyrosine concentration by reduction or discontinuation of nitisinone, since the metabolic defect may result in deterioration of the patient’ s clinical condition.